Potent and selective inhibitor of dipeptidyl peptidase IV (DPPIV) (Ki=130 nM). May be used in cell cuture (1-10 µM) or in vivo (10 mg/kg orally). Cell permeable. Experimental anti-diabetic agent. This product not approved for human therapeutic use.
* VAT and and shipping costs not included. Errors and price changes excepted
